Melanoma-specific mortality and competing mortality in patients with non-metastatic malignant melanoma: a population-based analysis.

This large study cohort enabled us to build a reliable competing risk model and nomogram for predicting melanoma prognosis. Model performance proved to be good. This individualized predictive tool can be used in clinical practice to help treatment-related decision making.